rs140881518
Variant summary
Our verdict is Likely pathogenic. Variant got 7 ACMG points: 7P and 0B. PM2PP3_StrongPP5
The NM_052845.4(MMAB):c.521C>T(p.Ser174Leu) variant causes a missense, splice region change. The variant allele was found at a frequency of 0.0000329 in 1,609,622 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_052845.4 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MMAB | NM_052845.4 | c.521C>T | p.Ser174Leu | missense_variant, splice_region_variant | 7/9 | ENST00000545712.7 | NP_443077.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MMAB | ENST00000545712.7 | c.521C>T | p.Ser174Leu | missense_variant, splice_region_variant | 7/9 | 1 | NM_052845.4 | ENSP00000445920.1 |
Frequencies
GnomAD3 genomes AF: 0.0000658 AC: 10AN: 151920Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000644 AC: 16AN: 248484Hom.: 0 AF XY: 0.0000742 AC XY: 10AN XY: 134798
GnomAD4 exome AF: 0.0000295 AC: 43AN: 1457702Hom.: 0 Cov.: 35 AF XY: 0.0000358 AC XY: 26AN XY: 725408
GnomAD4 genome AF: 0.0000658 AC: 10AN: 151920Hom.: 0 Cov.: 30 AF XY: 0.0000674 AC XY: 5AN XY: 74176
ClinVar
Submissions by phenotype
Methylmalonic aciduria, cblB type Pathogenic:3Uncertain:3
Pathogenic, no assertion criteria provided | clinical testing | Baumgartner lab, University Children's Hospital Zurich | Jun 01, 2021 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Apr 07, 2020 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Mar 29, 2024 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Dec 18, 2017 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 16, 2024 | This sequence change replaces serine, which is neutral and polar, with leucine, which is neutral and non-polar, at codon 174 of the MMAB protein (p.Ser174Leu). This variant is present in population databases (rs140881518, gnomAD 0.04%). This missense change has been observed in individual(s) with MMAB-related conditions (PMID: 16410054, 23707710, 34796408; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 445684). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Oct 07, 2021 | - - |
MMAB-related disorder Pathogenic:1
Likely pathogenic, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Mar 13, 2024 | The MMAB c.521C>T variant is predicted to result in the amino acid substitution p.Ser174Leu. This variant was reported in the homozygous state in two individuals with methylmalonic aciduria (MMA), cblB type; at least one of the reported patients had the diagnosis of cblB type MMA confirmed by cellular complementation studies (Lerner-Ellis et al. 2006. PubMed ID: 16410054; Forny et al 2021. PubMed ID: 34796408). This variant was also reported in the heterozygous state without a second variant identified in a patient with undiagnosed MMA (Illson et al. 2013. PubMed ID: 23707710). This variant is reported in 0.036% of alleles in individuals of South Asian descent in gnomAD. This variant is interpreted as likely pathogenic. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Sep 18, 2017 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at